Skip to main navigation Skip to search Skip to main content

Trastuzumab emtansine for residual invasive HER2-positive breast cancer

Gunter Von Minckwitz, Chiun Sheng Huang, Max S. Mano, Sibylle Loibl, Eleftherios P. Mamounas, Michael Untch, Norman Wolmark, Priya Rastogi, Andreas Schneeweiss, Andres Redondo, Hans H. Fischer, William Jacot, Alison K. Conlin, Claudia Arce-Salinas, Irene L. Wapnir, Christian Jackisch, Michael P. DiGiovanna, Peter A. Fasching, John P. Crown, Pia WülfingZhimin Shao, Elena Rota Caremoli, Haiyan Wu, Lisa H. Lam, David Tesarowski, Melanie Smitt, Hannah Douthwaite, Stina M. Singel, Charles E. Geyer

Research output: Contribution to journal › Article › peer-review

2307   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Trastuzumab emtansine for residual invasive HER2-positive breast cancer'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science